GPAT2

Chr 2

glycerol-3-phosphate acyltransferase 2, mitochondrial

Also known as: CT123

The protein transfers acyl groups to glycerol-3-phosphate to produce lysophosphatidic acid, a critical step in triacylglycerol and glycerophospholipid biosynthesis, and is also required for piRNA biosynthesis. Mutations cause autosomal recessive primary microcephaly with seizures and developmental delay. The gene shows extremely high constraint against loss-of-function variants, indicating that complete loss of protein function is likely incompatible with normal development.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
11
Pubs (1 yr)
0
P/LP submissions
P/LP missense
1.12
LOEUF
Mechanism
Clinical SummaryGPAT2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.12LOEUF
pLI 0.000
Z-score 1.02
OE 0.80 (0.581.12)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.17Z-score
OE missense 1.03 (0.931.13)
295 obs / 287.0 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.80 (0.581.12)
00.351.4
Missense OE1.03 (0.931.13)
00.61.4
Synonymous OE1.10
01.21.6
LoF obs/exp: 24 / 30.0Missense obs/exp: 295 / 287.0Syn Z: -0.86

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

GPAT2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →